Akers Biosciences (AKR) - Holding(s) in Company RNS Number : 1660O Akers Biosciences, Inc. 08 October 2012 TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES^i 1. Identity of the issuer or the underlying issuer Akers Biosciences of existing shares to which voting rights are attached: ^ii ISIN: USU009441051 2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights x Other (please specify): 3. Full name of person(s) subject to the Commerzbank AG notification obligation: ^iii 4. Full name of shareholder(s) (if different from 3.):^iv 5. Date of the transaction and date on which the threshold is crossed or 4 October 2012 reached: ^v 6. Date on which issuer notified: 5 October 2012 7. Threshold(s) that is/are crossed or Below 5% reached: ^vi, vii 8. Notified details: A: Voting rights attached to shares ^viii, ix Class/type of Situation previous Resulting situation after the triggering shares to the triggering transaction transaction if possible Number Number Number Number of voting % of voting using of of of shares rights rights ^x the ISIN CODE Shares Voting Direct Direct Indirect Direct Indirect Rights ^xi ^xii USU009441051 8,728,500 8,728,500 8,728,500 8,728,500 3.51% B: Qualifying Financial Instruments Resulting situation after the triggering transaction Type of financial Expiration Exercise/ Number of voting % of voting instrument date ^xiii Conversion Period rights that may be rights ^xiv acquired if the instrument is exercised/ converted. n/a C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ^xv, xvi Resulting situation after the triggering transaction Type of Exercise Expiration Exercise/ Number of voting % of voting financial price date ^xvii Conversion rights instrument rights ^xix, instrument period refers to xx ^xviii Nominal Delta n/a Total (A+B+C) Number of voting rights Percentage of voting rights 8,728,500 3.51% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: ^xxi Proxy Voting: 10. Name of the proxy holder: 11. Number of voting rights proxy holder will cease to hold: 12. Date on which proxy holder will cease to hold voting rights: 13. Additional information: Lisa Carter 14. Contact name: Compliance Dept 15. Contact telephone number: 020 7475 5225 This information is provided by RNS The company news service from the London Stock Exchange END HOLUGGGAUUPPGUR -0- Oct/08/2012 11:00 GMT
Akers Biosciences AKR Holding(s) in Company
Press spacebar to pause and continue. Press esc to stop.